Last $7.24 USD
Change Today +0.25 / 3.58%
Volume 380.6K
PGNX On Other Exchanges
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Angelo William Lovallo Jr.

Principal Financial Officer, Principal Accounting Officer, Vice President of Finance and Treasurer, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Angelo William Lovallo, Jr. has been Treasurer of Progenics Pharmaceuticals, Inc. since 2011. Mr. Lovallo has been the Principal Financial Officer and Principal Accounting Officer of Progenics Pharmaceuticals, Inc. since October 1, 2012 and serves as its Senior Executive Director. Before joining Progenics in 2008 as Senior Director, Financial Reporting, Mr. Lovallo held Vice President, Financial Reporting positions at MBIA Inc. from 2004 to 2008 and AllianceBernstein ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.


Hofstra University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$279,591

Stock Options*

All Other Compensation$10,906
Exercisable Options22,708
Unexercisable Options57,667
Unexercisable Options Value$14,400
Total Value of Options$14,400
Total Number of Options80,375

Total Compensation*

Total Annual Cash Compensation$389,933
Total Short Term Compensation$279,591
Other Long Term Compensation$10,906
Total Calculated Compensation$566,290
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $7.24 USD +0.25


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at